Our portfolio

42 Active Ventures

Our portfolio consists of startups and scaleups covering a variety of industries, reflecting the broad research focus of our founding institutes. For more information about any of these ventures you can contact our investment managers.

42 results

Sort by

Developing rapid human gut microbiota analysis.

Developing bispecific antibodies to enhance cancer immunotherapy.

Modulating immune responses with glycan-modified antigens for autoimmune and oncology treatments.

Advancing new therapeutics for Type 1 Diabetes and autoimmune diseases.

Transforming content into audio-based e-learning for on-the-go learning.

Improving orthopedic diagnostics with advanced joint loading and imaging technology.

Harnessing microbiota-based products to combat cardiometabolic diseases.

Cellagenics

Scaling up therapeutic antibody production with STEP® technology.

Enhancing microscopes with low-power super-resolution imaging solutions.

Developing stool-based colorectal cancer screening for early detection.

Optimizing sleep quality with science-backed technology.

Providing advanced defect detection for carbon composites in aerospace and wind energy.

AI-driven oncology biomarker quantification for digital pathology.

Combining quantum computing and classical simulations for material science.

Revolutionizing scientific publishing with data-driven collaboration tools.

Portable laparoscopic training system for surgical skill development.

GuanaRep

Repurposing hypertension drugs for treating rare neurological diseases.

Innovating post-surgical care with advanced blood clot prevention devices.

Personalized e-health recovery plans for post-surgery rehabilitation.

Developing a bi-hormonal artificial pancreas for better diabetes management.

Adding the size dimension to optical spectroscopy.

AI-driven stroke treatment modeling for thrombectomy device development.

AI-powered patient monitoring to improve elderly care.

Discovering novel antibodies for cancer and infectious disease treatments.

Using AI to restructure audio data, such as podcasts and webinars.

Advancing nanotechnology with sustainable, solvent-free nanoparticle synthesis.

OpticsFoundry

Simplifying quantum technology, we robotically manufacture glued optical circuit boards, enabling easier design and production of complex optical systems.

Developing gene therapy solutions for heart rhythm disorders.

A citizen engagement platform for real-time polling and response aggregation.

Developing novel treatments for Parkinson’s disease and dopamine disorders.

RNA-based therapies for rare genetic heart diseases.

Reducing plastic waste and lowering CO2 emissions.

Investing in and developing molecular diagnostics for biotech innovation.

Portable neurophysiological research tools for EEG and behavioral studies.

Providing quantum-safe security solutions to protect organizations from future cyber threats.

Engineering antibodies to treat neurodegenerative and immune diseases.

Developing therapeutic antibodies for RSV and respiratory diseases.

Painless and accurate mammography technology for breast cancer detection.

Advancing molecular diagnostics for precision oncology and infectious diseases.

Enhancing plant growth with solar-powered nanotechnology.

Upcycling phosphate waste into sustainable industrial products.

AI-powered portable EEG for real-time stroke severity detection.

Our success stories

8 Exits

Developing local gene therapy for chronic diseases, Arthrogen utilizes viral-mediated gene transfer to treat conditions like rheumatoid arthritis.

Pioneering cancer vaccines, DCPrime leverages its DCOne® dendritic cell technology to develop innovative immunotherapies.

Data-driven rehabilitation for elderly hip fracture patients, boosting recovery and confidence.

Developing adaptive online learning systems.

Enhancing patient care with AI-driven radiology solutions for clinical practice.

Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.

Specializing in AI-powered audience intelligence, Sightcorp provides automated facial analysis and emotion recognition technology.

Pioneering gene therapy, uniQure develops transformative treatments using its AAV-based technology platform.

Our portfolio

Our success stories

Holdings of our founding institutes

Contact